Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity (ImmunoCo27)
Study of Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity, for 27 Years of Natural Evolution and on Treatment
Sponsor: ANRS, Emerging Infectious Diseases
Listed as NCT02886416, this observational or N/A phase trial focuses on HIV Infection and remains completed. Sponsored by ANRS, Emerging Infectious Diseases, it has been updated 12 times since 2016, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
-
Jan 2021 — Oct 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Oct 2018 — Nov 2020 [monthly]
Completed
Status: Not Yet Recruiting → Completed
-
Jun 2018 — Oct 2018 [monthly]
Not Yet Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ANRS, Emerging Infectious Diseases
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.